Selank
Selank overview

Selank

Nasal sprayrecommended

Strongest for cognitive enhancement

First effects15-30 minutes
Full benefitsWeek 1-2

Nasal Selank activates NMDA receptor binding sites that injection does not, making it genuinely stronger for cognitive enhancement and brain function. Direct nose-to-brain transport via olfactory pathways provides rapid onset in 15-30 minutes. Best for on-demand cognitive support and fast-acting anxiety relief.

Nasal spray protocols

ProtocolDoseFrequency
Mild anxiety/cognitive enhancement300mcg (1 spray)Once daily
Moderate anxiety relief600mcg (2 sprays)Once daily
Intensive anxiety treatment900mcg (3 sprays)Once daily or divided
As-needed anxiety relief300-600mcgAs needed (max 3x daily)
Cognitive enhancement before tasks300mcg30-60 min before cognitive demands

Protocols are from published research literature. This is not medical advice. Dosing should be determined by a licensed clinician.

What to expect

15-30 minutes

Enhanced cognitive clarity and focus. Calming effects begin.

First hour

Full cognitive and anti-anxiety effects.

4-6 hours

Effects taper. Duration shorter than injection but onset much faster.

Week 1-2

Effects build with regular use. Cognitive benefits accumulate.

What to know

  • Use only high-quality, properly stored nasal spray formulations
  • Do not use if nasal passages are congested or during active illness
  • Monitor for nasal irritation or dryness with prolonged use
  • Store in refrigerator, use within 30 days of opening
  • Consult healthcare provider for combining with nasal medications

Other ways to take Selank

How Selank works

Selank calms the nervous system by enhancing GABA activity, your brain's natural "slow down" signal, which reduces anxiety without sedation. It also balances serotonin and dopamine levels, improving mood and sharpening focus. On top of that, it boosts BDNF (a protein that supports learning and memory) in the hippocampus and helps regulate inflammatory signaling, which is why it also supports immune function.

Key research

Zozulia AA et al. · Zhurnal Nevrologii i Psikhiatrii · 2008
Medvedev VE et al. · Zhurnal Nevrologii i Psikhiatrii · 2014
Uchakina ON et al. · Zhurnal Nevrologii i Psikhiatrii · 2008
Dolotov OV et al. · Journal of Neurochemistry · 2006